Compare Indocement Tunggal Prakarsa Tbk (INTP) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Indocement Tunggal Prakarsa Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Indocement Tunggal Prakarsa Tbk trades at Rp4,700 (market cap 16.14T, 783.2K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume). The key difference: Indocement Tunggal Prakarsa Tbk is far larger — about 28× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (3.48M versus 783.2K). Which is the better fit depends on your goals.
| INTP | LABS | |
|---|---|---|
Market Cap | 16.14T | 576.7B |
Volume | 783.2K | 3.48M |
Lot | 7.83K | 34.82K |
Turnover | 3.66B | 522.79M |
Average Price | 4,667.02 | 150.13 |
Value | 3.66B | 522.79M |
Indicative Equilibrium Price | 4,700 | 148 |
Indicative Equilibrium Volume | 443 | 350 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Indocement Tunggal Prakarsa Tbk
PT Indocement Tungggal Prakarsa Tbk (The company) was incorporated in Indonesia on January 16, 1985 and the Ministry of Justice approved its deed of incorporation on May 17, 1985. The company’s articles of association have been amended from time to time, the latest of which was covered by notarial deed on august 21, 1997. The amendments made are primarily intended to align the company’s articles of association with the new corporate law No. 1 year 1995. The company started its commercial operations in 1985. the company is domiciled in Jakarta, while its factories are located in Citeureup and Cirebon, West Java. The company and its subsidiaries were a multibusiness group divided into Cement Business as the Group core business, and Other business. The Cement business mainly includes the operation of the eight integrated cement plants at its Citeureup-Bogor site, two integrated cement plants at its Palimanan - Cirebon site with a combined annual capacity of 10.9 million tons, consisting of 10.7 million tons of portland cement and 0.2 million tons of specialty (white and oil well) cements, and its ready mix concrete manufacturing subsudiary. Other business includes, among others, the operations of the company-owned property, Wisma Indosemen, a 23 storey office tower building with over 19,000 square meters of rentable space and two basement car parks and PT Wisma Nusantara International, an equitized subsidiary which owns and operates a 30 storey office building with 26,108 square meters of rentable space and President Hotel, a four star Hotel with 315 rooms. The above mentioned building are located in Jakarta’s central commercial district.
Read more on INTP →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
